First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13

被引:41
作者
Ekelund, C. K. [1 ]
Petersen, O. B. [2 ]
Skibsted, L. [3 ,4 ]
Kjaergaard, S. [5 ]
Vogel, I. [6 ]
Tabor, A. [1 ,4 ]
机构
[1] Rigshosp, Dept Fetal Med, DK-2100 Copenhagen, Denmark
[2] Skejby Univ Hosp, Dept Fetal Med, Aarhus, Denmark
[3] Roskilde Sygehus, Dept Fetal Med, Roskilde, Denmark
[4] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark
[5] Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark
[6] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus, Denmark
关键词
birth rates; Down syndrome; first-trimester screening; trisomy; 13; 18; FETAL NUCHAL-TRANSLUCENCY; PLASMA PROTEIN-A; FREE BETA-HCG; MATERNAL AGE; DOWN-SYNDROME; RISK; POPULATION; MULTICENTER; GESTATION; THICKNESS;
D O I
10.1002/uog.8929
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objectives In Denmark a new national guideline for prenatal screening and diagnosis was issued in 2004 according to which all pregnant women should be offered a first-trimester combined risk assessment for trisomy 21 (T21). The aim of this study was to investigate whether the new screening strategy for T21 has changed the gestational age at which trisomy 18 (T18) and trisomy 13 (T13) are diagnosed prenatally, and the number of infants born with T18 or T13. Methods We collected from the Danish Cytogenetic Central Register information on all prenatal and postnatal chromosome analyses for T18 or T13, registered from 1997 to 2007. Information on first-trimester screening results was collected from each department of obstetrics and gynecology performing the nuchal translucency scans. The cut-off used for referral to invasive diagnostic testing for T21 and for T18/T13 was 1 : 300 and 1 : 150 at screening, respectively. Results In total, there were 435 cases with T18 and 168 cases with T13 between 1997 and 2007 in Denmark. The estimated incidence of T18 and T13 at the time of delivery was calculated as 2.5 and 1.6 per 10 000 deliveries, respectively. The number (proportion) of cases diagnosed before week 18 increased significantly, from 63 (59.4%) in 1997 and 1998 to 90 (80.4%) in 2006 and 2007 (P < 0.001). In addition, the number of T18 and T13 cases diagnosed prenatally after week 22 or postnatally decreased significantly, from 34 (32.1%) in 1997 and 1998 to seven (6.3%) in 2006 and 2007 (P < 0.0001). For women participating in first-trimester risk assessment in 2006 and 2007, the detection rate of T18 and T13 was 78.8% (95% CI, 71.0-86.7%). Conclusion The number of T18 and T13 fetuses diagnosed before week 18 increased significantly after the introduction of a combined first-trimester screening strategy for T21 in Denmark. In addition, the total number of fetuses diagnosed late in pregnancy and infants born with T18 or T13 decreased significantly. The national detection rate for T18 and T13 in the first trimester is comparable with detection rates found in modeled datasets and other prospective studies. Copyright (C) 2011 ISUOG. Published by John Wiley & Sons, Ltd.
引用
收藏
页码:140 / 144
页数:5
相关论文
共 22 条
[1]   Risk factors for legal induced abortion-related mortality in the United States [J].
Bartlett, LA ;
Berg, CJ ;
Shulman, HB ;
Zane, SB ;
Green, CA ;
Whitehead, S ;
Atrash, HK .
OBSTETRICS AND GYNECOLOGY, 2004, 103 (04) :729-737
[2]   First- and second-trimester screening - Detection of aneuploidies other than down syndrome [J].
Breathnach, Fionnuala M. ;
Malone, Fergal D. ;
Lambert-Messerlian, Geralyn ;
Cuckle, Howard S. ;
Porter, T. Flint ;
Nyberg, David A. ;
Comstock, Christine H. ;
Saade, George R. ;
Berkowitz, Richard L. ;
Klugman, Susan ;
Dugoff, Lorraine ;
Craigo, Sabrina D. ;
Timor-Tritsch, Ilan E. ;
Carr, Stephen R. ;
Wolfe, Honor M. ;
Tripp, Tara ;
Bianchi, Diana W. ;
D'Alton, Mary E. .
OBSTETRICS AND GYNECOLOGY, 2007, 110 (03) :651-657
[3]   Womens' preference in Down syndrome screening [J].
de Graaf, IM ;
Tijmstra, T ;
Bieker, OP ;
van Lith, JMM .
PRENATAL DIAGNOSIS, 2002, 22 (07) :624-629
[4]  
Ekelund CK, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2547
[5]  
Ekelund Charlotte Kvist, 2010, Ugeskr Laeger, V172, P1759
[6]  
GOLDSTEIN H, 1988, CLIN GENET, V34, P366
[7]   Follow up and evaluation of the Victorian first-trimester combined screening programme for Down syndrome and trisomy 18 [J].
Jaques, A. M. ;
Halliday, J. L. ;
Francis, I. ;
Bonacquisto, L. ;
Forbes, R. ;
Cronin, A. ;
Sheffield, L. J. .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2007, 114 (07) :812-818
[8]   Screening for trisomy 18 by maternal age, fetal nuchal translucency, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A [J].
Kagan, K. O. ;
Wright, D. ;
Maiz, N. ;
Pandeva, I. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2008, 32 (04) :488-492
[9]   Prospective validation of first-trimester combined screening for trisomy 21 [J].
Kagan, K. O. ;
Etchegaray, A. ;
Zhou, Y. ;
Wright, D. ;
Nicolaides, K. H. .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2009, 34 (01) :14-18
[10]   Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free β-hCG and pregnancy-associated plasma protein-A [J].
Kagan, Karl O. ;
Wright, Dave ;
Valencia, Catalina ;
Maiz, Nerea ;
Nicolaides, Kypros H. .
HUMAN REPRODUCTION, 2008, 23 (09) :1968-1975